Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1637 1653
This examiner grants 61% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18283201 | PRIME EDITING-BASED SIMULTANEOUS GENOMIC DELETION AND INSERTION | Non-Final OA | UNIVERSITY OF MASSACHUSETTS |
| 17763716 | METHODS AND SYSTEMS FOR PREPARING A NUCLEIC ACID CONSTRUCT FOR SINGLE MOLECULE CHARACTERISATION | Non-Final OA | Oxford Nanopore Technologies PLC |
| 18271832 | RIBOZYME-ACTIVATED RNA CONSTRUCTS AND USES THEREOF | Non-Final OA | The Regents of the University of California |
| 17604128 | PROTEIN TRANSLATIONAL CONTROL | Final Rejection | The Regents of the University of California |
| 18485930 | RESCUE STRATEGIES FOR BEST1 LOSS- AND GAIN-OF-FUNCTION MUTATIONS | Non-Final OA | University of Rochester |
| 17633573 | BASE EDITORS WITH DIVERSIFIED TARGETING SCOPE | Final Rejection | President and Fellows of Harvard College |
| 17905457 | RNA-GUIDED GENOME RECOMBINEERING AT KILOBASE SCALE | Final Rejection | The Board of Trustees of the Leland Stanford Junior University |
| 18271417 | Methods to Quantify Rate of Clonal Expansion and Methods for Treating Clonal Hematopoiesis and Hematologic Malignancies | Non-Final OA | Vanderbilt University |
| 18273454 | ENHANCING EFFICIENCY OF TARGETED GENE KNOCKIN BY BASE EDITORS | Non-Final OA | REGENTS OF THE UNIVERSITY OF MINNESOTA |
| 17717697 | GENE EDITING TO CORRECT ANEUPLOIDIES AND FRAME SHIFT MUTATIONS | Final Rejection | The Trustees of Columbia University in the City of New York |
| 18301732 | GENOMIC EDITING WITH SITE-SPECIFIC RETROTRANSPOSONS | Non-Final OA | Massachusetts Institute of Technology |
| 17778192 | RETROTRANSPOSONS AND USE THEREOF | Non-Final OA | MASSACHUSETTS INSTITUTE OF TECHNOLOGY |
| 18328381 | REGULATION OF METABOLISM AND OBESITY BY MITOCHONDRIAL MUL1 E3 UBIQUITIN LIGASE | Non-Final OA | University of Central Florida Research Foundation, Inc. |
| 17980883 | METHODS OF GENOME EDITING INCLUDING CONTROLLED OPENING OF CHROMATIN | Final Rejection | Wisconsin Alumni Research Foundation |
| 18556180 | REDIRECTING RISC FOR RNA EDITING | Non-Final OA | ALNYLAM PHARMACEUTICALS, INC. |
| 17668413 | SMALL RIBOSOMAL PROTEIN SUBUNIT 25 (RPS25) iRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOF | Final Rejection | Alnylam Pharmaceuticals, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy